Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1119]

The promise of immunotherapy in head and neck, and prostate cancer

Dr Luis Larrea - NISA, Valencia, Spain

The promise of immunotherapy in head and neck, and prostate cancer ( Dr Luis Larrea - NISA, Valencia, Spain )

The 'My Health Avatar' app for iManageCancer

Prof Feng Dong - University of Bedfordshire, Luton, UK

Precision CAR T cell therapeutics

Prof Carl H. June - Perelman School of Medicine, Philadelphia, USA

Precision CAR T cell therapeutics ( Prof Carl H. June - Perelman School of Medicine, Philadelphia, USA )

MyPathway study: a novel precision oncology multiple basket trial

Dr Mary S. Beattie - Genentech, USA

MyPathway study: a novel precision oncology multiple basket trial ( Dr Mary S. Beattie - Genentech, USA )

Editor's Choice for June 2018

Prof Gordon McVie - Founding Editor, ecancer

Editor's Choice for June 2018 ( Prof Gordon McVie - Founding Editor, ecancer )

Disease management for mCRPC

Prof Nicholas Mottet, Dr Philipp Mandel and Prof Amit Bahl

Disease management for mCRPC ( Prof Nicholas Mottet, Dr Philipp Mandel and Prof Amit Bahl )

Advanced Prostate Cancer - The evolving landscape and targeted therapies

Prof Nicholas Mottet, Prof Amit Bahl, Prof Piet Ost and Dr Inge Van Oort

Advanced Prostate Cancer - The evolving landscape and targeted therapies ( Prof Nicholas Mottet, Prof Amit Bahl, Prof Piet Ost and Dr Inge Van Oort )

Highlights from PROSCA 2018: Imaging, biomarkers and genetic testing

Prof Noel Clarke, Prof Hardev Pandha, Prof Amit Bahl and Dr Nina Tunariu

Highlights from PROSCA 2018: Imaging, biomarkers and genetic testing ( Prof Noel Clarke, Prof Hardev Pandha, Prof Amit Bahl and Dr Nina Tunariu )

ASCO 2018 conference round up

Dr Bishal Gyawali and Will Davies

ASCO 2018 conference round up ( Dr Bishal Gyawali and Will Davies )

Phase II results of olaparib and abiraterone for mCRPC

Prof Noel Clarke - Salford Royal NHS Foundation Trust, Salford, UK

Phase II results of olaparib and abiraterone for mCRPC ( Prof Noel Clarke - Salford Royal NHS Foundation Trust, Salford, UK )

Key developments in non-metastatic and metastatic hormone-sensitive prostate...

Dr Eleni Efstathiou, Prof Nicholas Mottet, Dr Andrew Armstrong and Prof Maria...

Key developments in non-metastatic and metastatic hormone-sensitive prostate cancer ( Dr Eleni Efstathiou, Prof Nicholas Mottet, Dr Andrew Armstrong and Prof Maria De Santis )

Phase III results of PROSPECT study for metastatic, castration-resistant...

Dr James Gulley - Center for Cancer Research, Washington, USA

Phase III results of PROSPECT study for metastatic, castration-resistant prostate cancer ( Dr James Gulley - Center for Cancer Research, Washington, USA )

More from ecancer